Review: Cannabinoids and codeine have similar effects on pain relief, but cannabinoids commonly cause adverse psychotropic effects

Kinzbrunner, Barry M.
January 2002
ACP Journal Club;Jan/Feb2002, Vol. 136 Issue 1, p18
Academic Journal
Presents an abstract of the study 'Are Cannabinoids an Effective and Safe Treatment Option in the Management of Pain? A Qualitative Systematic Review,' by F. A. Campbell, M. R. Tramèr, D. Carroll, et al., published on the July 7, 2001 issue of the 'British Medical Journal.' Comment on the study.


Related Articles

  • Cannabinoids in pain and inflammation. Mbvundula, Estery C.; Rainsford, K. D.; Bunning, Rowena A. D. // Inflammopharmacology;2004, Vol. 12 Issue 2, p99 

    Cannabinoids exhibit medicinal properties including analgesic, anti-inflammatory and immunosuppressive properties. This paper reviews some of the recent findings in the study of cannabinoids in pain and inflammation. Some of the effects of cannabinoids are receptor mediated and others are...

  • Cannabinoids for pain and nausea. Kalso, Eija // BMJ: British Medical Journal (International Edition);7/7/2001, Vol. 323 Issue 7303, p2 

    Discusses the debate about the therapeutic use of cannabinoids, including demands for their more liberal availability. Suggested therapeutic value of cannabinoids as analgesics and in various conditions, including migraine headaches, nausea and vomiting, and appetite stimulation in HIV-infected...

  • Local activation of cannabinoid CB1 receptors in the urinary bladder reduces the inflammationinduced sensitization of bladder afferents. Walczak, Jean-Sébastien; Cervero, Fernando // Molecular Pain;2011, Vol. 7 Issue 1, p31 

    Background: Systemic administration of cannabinoid agonists is known to reduce pain induced by bladder inflammation and to modulate cystometric parameters in vivo. We have previously reported that intravesical administration of a cannabinoid agonist reduces the electrical activity of bladder...

  • Role of Cannabinoids in the Management of Neuropathic Pain. Fontelles, M. Isabel Martín; García, Carlos Goicoechea // CNS Drugs;2008, Vol. 22 Issue 8, p645 

    The treatment of pain, particularly neuropathic pain, is one of the therapeutic applications of cannabis and cannabinoids that is currently under investigation and that stimulates interest among clinicians and basic researchers. Animal pain models, including models of acute, antinociceptive,...

  • Dynorphin A Peptides: Potential Role in Pain Transmission and Therapy. Schäfer, M.; Brack, A.; Stein, C. // CNS Drugs;2000, Vol. 13 Issue 3, p161 

    Dynorphin (DYN) is a potent endogenous opioid peptide which binds with high affinity to the κ-opioid receptor and has lower affinity for other opioid and non-opioid [N-methyl-D-aspartate (NMDA)] receptors. This pharmacological profile may explain the conflicting results obtained with DYN in...

  • Effect of Cannabinoid Receptor Activation on Spreading Depression. Kazemi, Hadi; Rahgozar, Mehdi; Speckmann, Erwin-Josef; Gorji, Ali // Iranian Journal of Basic Medical Sciences;Jul/Aug2012, Vol. 15 Issue 4, p926 

    Objective(s) The objective of this study was to evaluate the effect of cannabinoid on cortical spreading depression (CSD) in rat brain. Cannabis has been used for centuries for both symptomatic and prophylactic treatment of different types of headaches including migraine. CSD is believed to be a...

  • Role of Cannabinoids in the Treatment of Pain and (Painful) Spasticity. Karst, Matthias; Wippermann, Sonja; Ahrens, Jörg // Drugs;2010, Vol. 70 Issue 18, p2409 

    Both the discovery of the endocannabinoid system (ECS) and its role in the control of pain and habituation to stress, as well as the significant analgesic and antihyperalgesic effects in animal studies, suggest the usefulness of cannabinoids in pain conditions. However, in human experimental or...

  • Cannabinoids for chronic pain. Cohen, Steven P. // BMJ: British Medical Journal (International Edition);1/26/2008, Vol. 336 Issue 7637, p167 

    The author reflects on the use of cannabinoids such as dihydrocodeine for the treatment of chronic pain in patients. He suggests that evidence for the effectiveness of cannabinoids for treating cancer is strong, but that the evidence for the effectiveness of cannabinoids for treating acute pain...

  • Actions of N-arachidonyl-glycine in a rat inflammatory pain model. Succar, Rebecca; Mitchell, Vanessa A.; Vaughan, Christopher W. // Molecular Pain;2007, Vol. 3, p24 

    Background: While cannabinoid receptor agonists have analgesic activity in inflammatory pain states they produce a range of side effects. Recently, it has been demonstrated that the arachidonic acid-amino acid conjugate, N-arachidonyl-glycine (NA-glycine) is effective in acute pain models....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics